ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag art policy innovation cancer

2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Policy
The Scientist Staff | Feb 22, 1987 | 10+ min read
For psychiatrist David A. Hamburg, an early interest in biobehavioral aspects of stress and aggression has broadened to embrace many issues in education, health and public policy. After brief stints at Walter Reed Army Institute of Medical Research and as chief of the adult psychiatry branch at the National Institute of Mental Health, he established the psychiatry department at Stanford University's medical school in 1961. Hamburg left Stan-ford in 1975 to become president of the Institute of Me
Top 10 Innovations 2016
The Scientist | Dec 1, 2016 | 10+ min read
This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.
Photograph of scientists working while wearing PPE
Contract Vivarium Facilities for Preclinical Discovery
The Scientist and Mispro | Mar 30, 2023 | 3 min read
Researchers rent contract vivarium space for greater experimental control, productivity, and reproducibility when developing new therapeutics.
Harvard Biochemist Jeremy Knowles Named To Top Arts And Sciences Post
Barbara Spector | Aug 18, 1991 | 5 min read
Harvard Biochemist Jeremy Knowles Named To Top Arts And Sciences Post Veteran Computer Systems Designer Mayo Takes Helm as Bell Labs seventh President John L. Zabriskie Robert Gall Thomas Waldman Jeremy R. Knowles, a British-born chemist who has been at Harvard University since 1974, has been appointed dean of the Faculty of Arts and Sciences. In his new job, second in importance only to the presidency, Knowles oversees the finances, organization, and educational policies of Harvard Co
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
Exclusion Of Diversity And Creativity Impedes Scientific Innovation
Fred Cowan | Nov 26, 1995 | 7 min read
Scientific Innovation Author: Fred M. Cowan The "information age" with accompanying "big science" has emphasized data generation, analytical thinking, and specialization. This may have had the unfortunate consequence of segregating mainstream science from the novel and abstract ideas, often created at the margins of science, that stimulate rapid progress and invention. Has too narrow a focus on empirical phenomena slowed the innovations that benefit society and prove the utility of science?
Those We Lost in 2018
Ashley Yeager | Dec 26, 2018 | 10+ min read
The scientific community said goodbye to a number of leading researchers this year.
Debt Ceiling Bill May Hurt Science
Tia Ghose | Aug 2, 2011 | 5 min read
The bill to raise the debt ceiling and reduce the deficit would slash billions of dollars for basic scientific and medical research.
Human Clinical Trials Begin For Cervical Cancer Vaccines
Steve Bunk | Oct 26, 1997 | 6 min read
Efforts are under way to develop a vaccine against one of the world's deadliest illnesses, cervical cancer. Along with a number of university research laboratories, at least a half-dozen biotechnology and pharmaceutical companies are beginning clinical trials or are in preclinical development of such drugs. Efficacy in humans remains to be firmly established, but if the vaccines progress to later-phase trials, challenging jobs for immunologists, microbiologists, and biochemists will multiply. "

Run a Search

ADVERTISEMENT